{
    "medicine_id": "6bc114b6c24de96704348250a328857a5db47692",
    "platform_id": "DB00062",
    "metadata": {
        "name": "Albuked 2 5 g 50mL Solution",
        "composition": "2 5 g 50mL Albumin human",
        "clinical_particulars": {
            "therapeutic_indications": "Albuminex solution is indicated for adults and children for hypovolemia ascites hypoalbuminemia including from burns acute nephrosis acute respiratory distress syndrome and cardipulmonary bypass F229",
            "contraindications": {
                "disease": "In general human albumin solutions are well tolerated and no specific clinically relevant alterations in organ function or coagulopathy have been substantiated F229 The most common adverse reactions are rigors hypotension tachycardia with increased heart rate fever chills nausea vomiting dyspnea and or bronchospasm skin rash pruritus Stop the infusion immediately if anaphylaxis with or without shock is observed F229 Hypervolemia may occur if the dosage and rate of infusion are not adjusted to the volume status of the patient When clinical signs of cardiovascular overload occur headache dyspnea jugular venous distention increased blood pressure the infusion must be slowed or stopped immediately F230",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Serum albumin is a soluble monomeric protein essential for maintaining and regulating the colloidal osmotic pressure of blood It is utilized to increase the circulating plasma volume which reduces hemoconcentration and blood viscosity Albumin is also used as a transport protein that binds naturally occurring therapeutic and toxic materials and drugs in the circulation F229 Human albumin makes up over 50 the total protein in the plasma and represents about 10 of protein synthesis activity by the liver Human Albumin 25 has a corresponding hyper oncotic effect F230",
                "excipients": "NA",
                "incompatibilities": []
            }
        },
        "revision_date": "2023-05-14"
    }
}